Literature DB >> 30698643

Making immunotherapy 'cold' tumours 'hot' by chemotherapy-induced mutations-a misconception.

T Helleday1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30698643     DOI： 10.1093/annonc/mdz013

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer.

Authors:  Theodore S Hong; Eliezer M Van Allen; Sophia C Kamran; Jochen K Lennerz; Claire A Margolis; David Liu; Brendan Reardon; Stephanie A Wankowicz; Emily E Van Seventer; Adam Tracy; Jennifer Y Wo; Scott L Carter; Henning Willers; Ryan B Corcoran
Journal:  Clin Cancer Res       Date:  2019-06-28       Impact factor: 12.531

2.  Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer.

Authors:  G Serna; F Ruiz-Pace; J Hernando; L Alonso; R Fasani; S Landolfi; R Comas; J Jimenez; E Elez; S Bullman; J Tabernero; J Capdevila; R Dienstmann; P Nuciforo
Journal:  Ann Oncol       Date:  2020-06-20       Impact factor: 32.976

Review 3.  Therapeutic strategies to remodel immunologically cold tumors.

Authors:  Minyu Wang; Sen Wang; Jayesh Desai; Joseph A Trapani; Paul J Neeson
Journal:  Clin Transl Immunology       Date:  2020-12-08

Review 4.  The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy.

Authors:  Maurice Michel; Leonard Kaps; Annett Maderer; Peter R Galle; Markus Moehler
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

5.  Genetic instability as a driver for immune surveillance.

Authors:  Guim Aguadé-Gorgorió; Ricard Solé
Journal:  J Immunother Cancer       Date:  2019-12-11       Impact factor: 13.751
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.